• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926024220
Medical Device Problem Code Bent (1059)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 04/11/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).Device evaluated by mfr: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in the left anterior descending (lad) artery.A 2.25 x 24 synergy ii drug-eluting stent was advanced to treat the lesion.However, the proximal edge of the stent was crumpled about 5mm distal to the proximal radiopaque marker.The device was pulled out and the procedure was completed with implantation of two different synergy stents.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device lot number corrected from 20192166 to 0019299729.Device expiration date corrected from 01/19/2018 to 05/17/2017.Device manufactured date corrected from 01/31/2017 to 06/13/2016.(b)(4).Synergy ii us mr 2.25 x 24mm stent delivery system (sds) was returned for analysis.A visual and microscopic examination of the crimped stent identified stent damage and distal movement on the balloon.Stent was severely damaged and bunched at the center.Proximal end of stent had moved distally on the balloon such that the proximal end of the stent was 8mm distal from the distal edge of the proximal marker band.The distal end of the stent had moved slightly distally on the balloon.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.Crimp markings evident on exposed proximal balloon wall, indicating correct positioning and crimping of the stent prior to the complaint incident.A visual and tactile examination of the hypotube found multiple hypotube kinks.A visual and tactile examination of shaft polymer extrusion revealed no issues.A visual and microscopic examination of the tip found no issues.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in the left anterior descending (lad) artery.A 2.25 x 24 synergy ii drug-eluting stent was advanced to treat the lesion.However, the proximal edge of the stent was crumpled about 5mm distal to the proximal radiopaque marker.The device was pulled out and the procedure was completed with implantation of two different synergy stents.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key6534062
Report Number2134265-2017-04190
Device Sequence Number1266886
Product Code NIQ
UDI-Device Identifier08714729840206
UDI-Public(01)08714729840206(17)20180119(10)20192166
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/17/2017
Device Model NumberH7493926024220
Device Catalogue Number39260-2422
Device Lot Number0019299729
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/05/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 04/11/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date05/01/2017
Supplement Report FDA Received Date06/12/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-